Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5587)
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$86.62
Total Value
$303.17K
Shares Held After
153,902
% of Holdings
2.2%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
27,600
Price
$8.52
Total Value
$235.28K
Shares Held After
1,366,053
% of Holdings
2.0%
GLAUKOS Corp (GKOS)
Thurman Alex R. — SVP & CHIEF FINANCIAL OFFICER
Shares
10,000
Price
$150.00
Total Value
$1.50M
Shares Held After
43,681
% of Holdings
18.6%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
1,000
Price
$280.00
Total Value
$280.00K
Shares Held After
4,000
% of Holdings
20.0%
Warby Parker Inc. (WRBY)
Gilboa David Abraham — Director
Shares
54,347
Price
$29.84
Total Value
$1.62M
Shares Held After
31,112
% of Holdings
63.6%
Warby Parker Inc. (WRBY)
Blumenthal Neil Harris — Director
Shares
9,200
Price
$29.99
Total Value
$275.91K
Shares Held After
31,112
% of Holdings
22.8%
PUMA BIOTECHNOLOGY, INC. (PBYI)
HUNT DOUGLAS M — The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
Shares
8,460
Price
$8.26
Total Value
$69.90K
Shares Held After
196,841
% of Holdings
4.1%
PUMA BIOTECHNOLOGY, INC. (PBYI)
NOUGUES MAXIMO F — Chief Financial Officer
Shares
9,386
Price
$8.26
Total Value
$77.56K
Shares Held After
230,637
% of Holdings
3.9%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
27,062
Price
$2.49
Total Value
$67.38K
Shares Held After
2,668,370
% of Holdings
1.0%
PUMA BIOTECHNOLOGY, INC. (PBYI)
AUERBACH ALAN H — Director
Shares
44,058
Price
$8.26
Total Value
$364.05K
Shares Held After
7,261,671
% of Holdings
0.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
50
Price
$124.74
Total Value
$6.24K
Shares Held After
175,000
% of Holdings
0.0%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,221
Price
$124.04
Total Value
$151.46K
Shares Held After
175,050
% of Holdings
0.7%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
2,324
Price
$123.25
Total Value
$286.43K
Shares Held After
176,271
% of Holdings
1.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
586
Price
$122.08
Total Value
$71.54K
Shares Held After
178,595
% of Holdings
0.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
444
Price
$120.69
Total Value
$53.59K
Shares Held After
179,181
% of Holdings
0.2%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
591
Price
$119.67
Total Value
$70.73K
Shares Held After
179,625
% of Holdings
0.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,034
Price
$118.81
Total Value
$122.85K
Shares Held After
180,216
% of Holdings
0.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
50
Price
$124.74
Total Value
$6.24K
Shares Held After
181,250
% of Holdings
0.0%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,221
Price
$124.04
Total Value
$151.46K
Shares Held After
181,300
% of Holdings
0.7%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
2,323
Price
$123.25
Total Value
$286.30K
Shares Held After
182,521
% of Holdings
1.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
587
Price
$122.08
Total Value
$71.66K
Shares Held After
184,844
% of Holdings
0.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
444
Price
$120.69
Total Value
$53.59K
Shares Held After
185,431
% of Holdings
0.2%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
591
Price
$119.67
Total Value
$70.73K
Shares Held After
185,875
% of Holdings
0.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,034
Price
$118.81
Total Value
$122.85K
Shares Held After
186,466
% of Holdings
0.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
194
Price
$124.61
Total Value
$24.18K
Shares Held After
0
% of Holdings
100.0%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,642
Price
$123.81
Total Value
$203.29K
Shares Held After
194
% of Holdings
89.4%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,945
Price
$123.07
Total Value
$239.37K
Shares Held After
1,836
% of Holdings
51.4%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
349
Price
$121.84
Total Value
$42.52K
Shares Held After
3,781
% of Holdings
8.5%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
570
Price
$120.66
Total Value
$68.78K
Shares Held After
4,130
% of Holdings
12.1%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,138
Price
$119.36
Total Value
$135.84K
Shares Held After
4,700
% of Holdings
19.5%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
412
Price
$118.49
Total Value
$48.82K
Shares Held After
5,838
% of Holdings
6.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
622
Price
$124.61
Total Value
$77.51K
Shares Held After
6,250
% of Holdings
9.1%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
5,253
Price
$123.81
Total Value
$650.37K
Shares Held After
6,872
% of Holdings
43.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
6,223
Price
$123.07
Total Value
$765.87K
Shares Held After
12,125
% of Holdings
33.9%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,115
Price
$121.84
Total Value
$135.85K
Shares Held After
18,348
% of Holdings
5.7%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,828
Price
$120.66
Total Value
$220.57K
Shares Held After
19,463
% of Holdings
8.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
3,639
Price
$119.36
Total Value
$434.37K
Shares Held After
21,291
% of Holdings
14.6%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
1,320
Price
$118.49
Total Value
$156.40K
Shares Held After
24,930
% of Holdings
5.0%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
20,000
Price
$2.05
Total Value
$41.04K
Shares Held After
386,904
% of Holdings
5.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
35,770
Price
$0.32
Total Value
$11.45K
Shares Held After
107,429
% of Holdings
25.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
100,019
Price
$22.79
Total Value
$2.28M
Shares Held After
875,912
% of Holdings
10.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
127,182
Price
$22.79
Total Value
$2.90M
Shares Held After
1,217,537
% of Holdings
9.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
253,039
Price
$22.79
Total Value
$5.77M
Shares Held After
4,223,448
% of Holdings
5.7%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$18.69
Total Value
$331.13K
Shares Held After
159,744
% of Holdings
10.0%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
5,889
Price
$50.84
Total Value
$299.42K
Shares Held After
41,884
% of Holdings
12.3%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
4,111
Price
$49.98
Total Value
$205.48K
Shares Held After
47,773
% of Holdings
7.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
2,474
Price
$87.03
Total Value
$215.31K
Shares Held After
60,299
% of Holdings
3.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
10,090
Price
$86.32
Total Value
$870.97K
Shares Held After
60,299
% of Holdings
14.3%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
8,786
Price
$85.35
Total Value
$749.89K
Shares Held After
70,389
% of Holdings
11.1%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
385
Price
$86.34
Total Value
$33.24K
Shares Held After
60,299
% of Holdings
0.6%
Showing 751–800 of 5587 transactions (page 16 of 112)